Get startedLog in
    Picture of Alligator Bioscience AB logo

    ATORX — Alligator Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development

    Picture of Alligator Bioscience AB logoAlligator Bioscience AB
    10/04/2026 13:54
    April 10 (Reuters) - Alligator Bioscience AB ATORX.ST:

 SIGNS LETTER-OF-INTENT WITH UNICANCER FOR PHASE 3 MITAZALIMAB DEVELOPMENT

AND UNICANCER TO PREPARE GLOBAL INVESTIGATOR SPONSORED PHASE 3 STUDY

Source text: ID:nMFN1g4YT2

Further company coverage: ATORX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Alligator Bioscience AB

    See all news